NIH #5R01CA255242-05
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
- Amount
- $640K
- Period
- 2021-02-03 → 2027-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at ROSWELL PARK CANCER INSTITUTE CORP
Cancer Genomics and Diagnostics · Cancer Research
14 total · 1 active
NIH #5R01CA255242-05
Awarded at ROSWELL PARK CANCER INSTITUTE CORP
NIH #5R01CA255242-04
Awarded at ROSWELL PARK CANCER INSTITUTE CORP
NIH #5R01CA255242-03
Awarded at ROSWELL PARK CANCER INSTITUTE CORP
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Journal of Investigative Dermatology · 2026-06-01
Discover Oncology · 2026-05-02
The Journal of Immunology · 2025-11-01
Annals of Oncology · 2025-09-01
Gynecologic Oncology · 2025-09-01
Mutational landscape of triple-negative breast cancer in African American women
Nature Genetics · 2025-08-26 · 7 citations
Journal of Investigative Dermatology · 2025-07-21
Journal of Investigative Dermatology · 2025-07-21
Health Science Reports · 2025-07-01
Journal of Clinical Oncology · 2025-05-28
Frontiers in Pharmacology · 2025-01-06 · 8 citations
102P Prognostic model of pediatric AML patients with RUNX1-RUNX1T1 fusion gene
ESMO Open · 2024-10-01
Isolation and pathogenicity of a fowl adenovirus 8b (FAdV-8b) strain in Cherry Valley ducks
Avian Pathology · 2024-09-25
830P Prognostic model of pediatric AML patients with RUNX1-RUNX1T1 fusion gene
Annals of Oncology · 2024-09-01
British Journal of Dermatology · 2024-08-27 · 3 citations